Speciality: Infectious diseases
Description:
A warm welcome to all the medical professionals in this interesting session on Omicron: What to know about this new COVID-19 variant? - By Dr. Preeti Parmar
Dr. Preeti Parmar provides a comprehensive overview of Omicron, a new COVID-19 variant that has become a significant concern globally. Identified first in South Africa in late 2021, Omicron is notable for its extensive
mutations in the spike protein, which impact the virus's transmissibility and immune evasion capabilities.
Omicron's high number of mutations has made it more transmissible than previous variants. Dr. Parmar explains that this has led to rapid increases in case numbers worldwide, even in populations with high vaccination rates. While early data suggests that Omicron may result in milder illness compared to the Delta variant, its enhanced spread poses substantial risks, especially to healthcare systems already burdened by the pandemic.
Vaccination remains a key strategy in combating Omicron. Dr. Parmar highlights that booster doses significantly improve protection against this variant, reinforcing the need for booster
campaigns. Moreover, she stresses the importance of maintaining other public health measures such as mask-wearing, social distancing, and regular testing to control its spread.
Therefore, get an overall knowledge of omicron: what to know about this new covid-19 variant? - By Dr. Preeti Parmar
See More Webinars @ Hidoc Webinars
1.
Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.
2.
Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.
3.
Long-term study links chronic conditions in midlife to higher cancer risk and mortality
4.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
5.
When does a melanoma metastasize? Implications for management
1.
Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results
2.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
3.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
4.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
5.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation